7-Nitroindazole blocks conditioned place preference but not hyperactivity induced by morphine

Behavioural Brain Research

Volumn 150, Issue 1-2, 2004, Pages 73-82

  Manzanedo, Carmen ^a   Aguilar, María A ^b   Rodríguez Arias, Marta ^b   Navarro, Miguel ^a   Miñarro, José ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

7 Nitroindazole; CPP; Morphine; Motor activity; Place conditioning

Indexed keywords

7 NITROINDAZOLE; MORPHINE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; HYPERACTIVITY; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HYPERKINESIS; INDAZOLES; MALE; MICE; MORPHINE; MOTOR ACTIVITY; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; REWARD;

EID: 1642386875     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(03)00225-0     Document Type: Article

References (85)

1. Afanas'ev I., Ferger B., Kuschinsky K. The associative type of sensitization to D-amphetamine is expressed as an NO-dependent dramatic increase in extracellular dopamine in the nucleus accumbens. Naunyn-Schmiedeberg's Arch. Pharmacol. 362:2000;232-237.
2. Araki T., Mizutani H., Matsubara M., Imai Y., Mizugaki M., Itoyama Y. Nitric oxide synthase inhibitors cause motor deficits in mice. Eur. J. Pharmacol. 11:2001;125-133.
3. Babbedge R.C., Bland-Ward P.A., Hart S.L., Moore P.K. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br. J. Pharmacol. 110:1993;225-228.
4. Brignola G., Calignano A., Di Rosa M. Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br. J. Pharmacol. 113:1994;1372-1376.
5. Calignano A., Persico P., Mancuso F., Sorrentino L. Endogenous nitric oxide modulates morphine-induced changes in locomotion and food intake in mice. Eur. J. Pharmacol. 231:1993;415-419.
6. Callahan B.T., Ricaurte G.A. Effect of 7-nitroindazole on body temperature and methamphetamine-induced dopamine toxicity. Neuroreport. 9:1998;2691-2695.
7. Celik T., Zaglí U., Kayír H., Uzbay I.T. Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice. Drug Alcohol Depend. 56:1999;109-113.
8. Chaparro-Huerta V., Beas-Zarate C., Guerrero M.U., Feria-Velasco A. Nitric oxide involvement in regulating the dopamine transport in the striatal region of rat brain. Neurochem. Int. 31:1997;607-616.
9. Collins S.L., Kantak K.M. Neuronal nitric oxide synthase inhibition decreases cocaine self-administration behavior in rats. Psychopharmacology. 159:2002;361-369.
10. Cunningham C.L., Niehus J.S. Drug-induced hypothermia and conditioned place aversion. Behav. Neurosci. 107:1993;468-479.
11. Del Bel E.A., Souza Ç.S., Guimaräes F.S., da-Silva C.A., Nucci-da-Silva L.P. Motor effects of acute and chronic inhibition of nitric oxide synthesis in mice. Psychopharmacology. 161:2002;32-37.
12. Di Monte D.A., Royland J.E., Jakowec M.W., Langston J.W. Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J. Neurochem. 67:1996;2443-2450.
13. Du W., Weiss H., Harvey J.A. Associative learning is enhanced by selective neuronal nitric oxide synthase inhibitors and retarded by a nitric oxide nodor in the rabbit. Psychopharmacology. 150:2000;264-271.
14. Dzoljic E., De Vries R., Dzoljic M.R. New and potent inhibitors of nitric oxide synthase reduce motor activity in mice. Behav. Brain Res. 87:1997;209-212.
15. East S.J., Parry-Jones A., Brotchie J.M. Ionotropic glutamate receptors and nitric oxide synthesis in the rat striatum. Neuroreport. 8:1996;71-75.
16. Faro L.R., do Nascimento J.L., Alfonso M., Duran R. Protection of methylmercury effects on the in vivo dopamine release by NMDA receptor antagonists and nitric oxide synthase inhibitors. Neuropharmacology. 42:2002;612-618.
17. Getting S.J., Segieth J., Ahmad S., Biggs C.S., Whitton P.S. Biphasic modulation of GABA release by nitric oxide in the hippocampus of freely moving rats in vivo. Brain Res. 717:1996;196-199.
18. Gholami A., Haeri-Rohani A., Sahraie H., Zarrindast M.-R. Nitric oxide mediation of morphine-induced place preference in the nucleus accumbens of rat. Eur. J. Pharmacol. 449:2002;269-277.
19. Gholami A., Zarrindast M.-R., Sahraci H., Haerri-Rohani A. Nitric oxide within the ventral tegmental area is involved in mediating morphine reward. Eur. J. Pharmacol. 458:2003;119-128.
20. Gracy K.N., Pickel V.M. Ultrastructural localization and comparative distribution of nitric oxide synthase and N-methyl-D-aspartate receptors in the shell of the rat nucleus accumbens. Brain Res. 747:1997;259-272.
21. Harlan R.E., Webber D.S., Garcia M.M. Involvement of nitric oxide in morphine-induced c-Fos expression in the rat striatum. Brain Res. Bull. 54:2001;207-212.
22. Hidaka S., Totterdell S. Ultrastructural features of the nitric oxide synthase-containing interneuron in the nucleus accumbens and their relationship with tyrosine hydroxylase-containing terminals. J. Comp. Neurol. 431:2001;139-154.
23. Itzhak Y. Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J. Pharmacol. Exp. Ther. 282:1997;521-527.
24. Itzhak Y., Ali S.F. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J. Neurochem. 67:1996;1770-1773.
25. Itzhak Y., Martin J.L. Blockade of alcohol-induced locomotor sensitization and conditioned place preference in DBA mice by 7-nitroindazole. Brain Res. 858:2000;402-407.
26. Itzhak Y., Martin J.L. Effect of the neuronal nitric oxide synthase inhibitor 7-nitroindazole on methylphenidate-induced hyperlocomotion in mice. Behav. Pharmacol. 13:2002;81-86.
27. Itzhak Y., Ali S.F., Martin J.L., Black M.D., Huang P.L. Resistance of neuronal nitric oxide synthase-deficient mice to cocaine-induced locomotor sensitization. Psychopharmacology. 140:1998;378-386.
28. Itzhak Y., Gandia C., Huang P.L., Ali S.F. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J. Pharmacol. Exp. Ther. 284:1998;1040-1047.
29. Itzhak Y., Martin J.L., Black M.D., Huang P.L. The role of neuronal nitric oxide synthase in cocaine-induced conditioned place preference. Neuroreport. 9:1998;2485-2488.
30. Javelle N., Berod A., Renaud B., Lambas-Senas L. NO synthase inhibitors attenuate locus coeruleus catecholamine metabolism and behavior induced by morphine withdrawal. Neuroreport. 13:2002;725-728.
31. Johansson C., Jackson D.M., Svensson L. Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology. 131:1997;167-173.
32. Karami M., Zarrindast M.R., Spehri H., Sahraei H. Role of nitric oxide in the rat hippocampal CA1 area on morphine-induced conditioned place preference. Eur. J. Pharmacol. 449:2002;113-119.
33. Kendrich K.M., Guevara-Guzman R., de la Riva C., Christensen J., Ostergaard K., Mesón P.C. NMDA and kainate-evoked release of nitric oxide and classic transmitters in the rat striatum: in vivo evidence that nitric oxide may play a neuroprotective role. Eur. J. Neurosci. 8:1996;2619-2634.
34. Kivastik T., Rutkauskaite J., Zharkovsky A. Nitric oxide synthesis inhibition attenuates morphine-induced place preference. Pharmacol. Biochem. Behav. 53:1996;1013-1015.
35. Kurosaki R., Muramatsu Y., Matsubara M., Kato H., Imai Y., Itoyama Y.et al. Role of nitric oxide synthase against MPTP neurotoxicity in mice. Neurol. Res. 24:2002;655-662.
36. Li S.-M., Ren Y.-H., Zheng J.-W. Effect of 7-nitroindazole on drug-priming reinstatement of D-methamphetamine-induced conditioned place preference. Eur. J. Pharmacol. 443:2002;205-206.
37. Li S.-M., Yin L.-L., Shi H., Lin Z.-B., Zheng J.-W. The effect of 7-nitroindazole on the acquisition and expression of D-methamphetamine-induced place preference in rats. Eur. J. Pharmacol. 435:2002;217-223.
38. Liu J., Nickolenko J., Sharp F.R. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8537-8541.
39. 3H ]glutamate by striatal synaptosomes J. Neurochem. 63:1994;2108-2117.
40. Lue W.M., Su M.T., Lin W.B., Tao P.L. The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices. Eur. J. Pharmacol. 383:1999;129-135.
41. MacKenzie G.M., Rose S., Bland-Ward P.A., Moore P.K., Jenner P., Marsder C.D. Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. Neuroreport. 5:1994;1851-1852.
42. Manzanedo C., Aguilar M.A., Miñarro J. The effects of dopamine D2 and D3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice. Psychopharmacology. 143:1999;82-88.
43. Manzanedo C., Aguilar M.A., Rodríguez-Arias M., Miñarro J. Effects of dopamine with different receptor blockade profiles on morphine-induced place preference in male mice. Behav. Brain Res. 121:2001;189-197.
44. Manzanedo C., Aguilar M.A., Rodríguez-Arias M., Miñarro J. Effects of CGS 10746B on hyperactivity and place preference induced by morphine. Behav. Brain Res. 126:2001;23-32.
45. Martin J.L., Itzhak Y. 7-Nitroindazole blocks nicotine-induced conditioned place preference but not LiCl-induced conditioned place aversion. Neuroreport. 11:2000;947-949.
46. Moore P.K., Babbedge R.C., Wallace P., Gaffen Z.A., Hart S.L. 7-Nitro indazole, an inhibitor of nitric oxide synthase, exhibits anti-nociceptive activity in the mouse without increasing blood pressure. Br. J. Pharmacol. 108:1993;296-297.
47. Moore P.K., Wallace P., Gaffen Z., Hart S.L., Babbedge R.C. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol. 110:1993;219-224.
48. Noda Y., Yamada K., Furukawa H., Nabeshima T. Involvement of nitric oxide in phencyclidine-induced hyperlocomotion in mice. Eur. J. Pharmacol. 286:1995;291-297.
49. Nowak P., Brus R., Oswiecimska J., Sokola A., Kostrezewa R.M. 7-Nitroindazole enhances amphetamine-evoked dopamine release in rat striatum. An in vivo microdialysis and voltammetric study. J. Physiol. Pharmacol. 53:2002;251-263.
50. Papp M. Differential effects of short- and long-term antidepressant treatments on the food-induced place preference conditioning in rats. Behav. Pharmacol. 1:1989;69-74.
51. Papp M., Gruca P., Willner P. Selective blockade of drug-induced place preference conditioning by ACPC, a functional NDMA-receptor antagonist. Neuropsychopharmacology. 27:2002;727-743.
52. 3H ]dopamine uptake Brain Res. 641:1994;83-91.
53. Pokk P., Vali M. Effects of nitric oxide synthase inhibitors 7-NI, L-NAME, and L-NOARG in staircase test. Arch. Med. Res. 33:2002;265-268.
54. Prendergast M.A., Buccafusco J.J., Terry A.V. Jr. Nitric oxide synthase inhibition impairs spatial navigation learning and induces conditioned taste aversion. Pharmacol. Biochem. Behav. 57:1997;347-352.
55. Przegalinski E., Filip M. Nitric oxide (NO) pathway and locomotor hyperactivity towards dopaminomimetics in rats. Pol. J. Pharmacol. 49:1997;291-298.
56. Rocha B., Di Scala G., Jenck F., Moreau J.L., Sandner G. Conditioned place aversion induced by 5-HT(1C) receptor antagonists. Behav. Pharmacol. 4:1993;101-106.
57. Rodrigo J., Springall D.R., Uttenthal O., Bentura M.L., Abadia-Molina F., Riveros-Moreno V.et al. Localization of nitric oxide synthase in the adult rat brain. Philos. Trans. R. Soc. Lond. [Biol.]. 345:1994;175-221.
58. Rodríguez-Arias M., Broseta I., Aguilar M.A., Miñarro J. Lack of specific effects of selective D1 and D2 dopamine antagonist vs. Risperidone on morphine-induced hyperactivity. Pharmacol. Biochem. Behav. 66:2000;189-197.
59. Salter M., Duffy C., Garghwaite J., Strijbos P.J. Ex vivo measurement of brain tissue nitrite and nitrate accurately reflects nitric oxide synthase activity in vivo. J. Neurochem. 4:1996;1683-1690.
60. Schultz W., Tremblay L., Hollerman J.R. Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology. 37:1998;421-429.
61. Schuman E.M., Madison D.V. Nitric oxide and synaptic function. Annu. Rev. Neurosci. 17:1994;153-183.
62. Segieth J., Fowler L., Whitton P., Pearce B. Nitric oxide-mediated regulation of dopamine release in the hippocampus in vivo. Neuropharmacology. 39:2000;571-577.
63. Shim I., Kim H.T., Kim Y.H., Chun B.G., Hahm D.H., Lee E.H.et al. Role of nitric oxide synthase inhibitors and NMDA receptor antagonist in nicotine-induced behavioral sensitization in the rat. Eur. J. Pharmacol. 443:2002;119-124.
64. Shippenberg T.S., Herz A. Differential effects of mu and kappa opioid systems on motivational processes. NIDA Res. Monogr. 75:1986;563-566.
65. Silva M.T., Rose S., Hindmarsh J., Aislainter G., Gorrod J.W., Moore P.K.et al. Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by novel monosodium salt of 7-nitroindazole. Br. J. Pharmacol. 114:1995;257-258.
66. Smith J.C., Whitton P.S. The regulation of NMDA-evoked dopamine release by nitric oxide in the frontal cortex and raphe nuclei of the freely moving rat. Brain Res. 889:2001;57-62.
67. Starr M.S., Starr B.S. Do NMDA receptor-mediated changes in motor behaviour involve nitric oxide? Eur. J. Pharmacol. 272:1995;211-217.
68. Strasser A., McCarron R.M., Ishii H., Stanimirovic D., Spatz M. L-Arginine induces dopamine release from the striatum in vivo. Neuroreport. 5:1994;2298-2300.
69. Szabo C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res. Bull. 41:1996;131-141.
70. Tzschentke T., Schmidt W.J. N-Methyl-D-aspartic acid-receptor antagonists blocks morphine-induced conditioned place preference in rats. Neurosci. Lett. 1193:1995;37-40.
71. Uzbay I.T., Oglesby M.W. Nitric oxide and substance dependence. Neurosci. Biobehav. Rev. 25:2001;43-52.
72. Uzbay I.T., Erden B.F., Tapanyigit E.E., Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci. 61:1997;2197-2209.
73. Vanderschuren L.J.M.J., Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of pre-clinical studies. Psychopharmacology. 151:2000;99-120.
74. Vaupel D.B., Kimes A.S., London E.D. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal. Neuropsychopharmacology. 13:1995;315-322.
75. Vaupel D.B., Kimes A.S., London E.D. Comparison of 7-nitroindazole with other nitric oxide synthase inhibitors as attenuators of opioid withdrawal. Psychopharmacology. 118:1995;361-368.
76. Vaupel D.B., Kimes A.S., London E.D. Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur. J. Pharmacol. 324:1997;11-20.
77. Volke V., Soosaar A., Köks S., Bourin M., Männistö P.T., Vasar E. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology. 131:1997;399-405.
78. Wegener G., Volke V., Bandpey Z., Rosenberg R. Nitric oxide modulates lithium-induced conditioned taste aversion. Behav. Brain Res. 118:2001;195-200.
79. Wegener G., Volke V., Rosenberg R. Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo. Br. J. Pharmacol. 130:2000;575-580.
80. West A.R., Galloway M.P. Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms. Neuropharmacology. 36:1997;1571-1581.
81. West A.R., Grace A.A. Striatal nitric oxide signaling regulates the neuronal activity of midbrain dopamine neurons in vivo. J. Neurophysiol. 83:2000;1796-1808.
82. Yildiz F., Ulak G., Erden B.F., Gacar N. Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test. Pharmacol. Biochem. Behav. 65:2000;199-202.
83. Zarrindast M.R., Karami M., Sepehri H., Sahraei H. Influence of nitric oxide on morphine-induced conditioned place preference in the rat central amygdala. Eur. J. Pharmacol. 453:2002;81-89.
84. Zhu H., Barr G.A. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists. Psychopharmacology. 150:2000;325-336.
85. Zhu X.Z., Luo L.G. Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J. Neurochem. 59:1992;932-935.